Keytruda is not only Merck & Co.’s top product but also one of the best-selling drugs worldwide, generating some 11 billion U.S. dollars in revenue during 2019. The cancer drug with the generic name pembrolizumab increased its revenues for some four billion U.S. dollars compared to 2018. Another of Merck’s top ranked pharmaceuticals based on […]